Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III placebo-controlled study of JYP0061 in adults with moderate-to-severe atopic dermatitis
CTR20262117Phase 3Active
- Sponsor
- Guangzhou JOYO Pharma
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of JYP0061 in atopic dermatitis (AD), sponsored by Guangzhou JOYO Pharma. Started Jun 2026; status: active.
02
Drugs
JYP0061
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20262117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262117.